Navigation Links
Humphrey Matrix Perimeter

ProductsHumphrey Matrix Perimeter
Company Carl Zeiss Meditec, Inc.
Item Humphrey Matrix Perimeter
Features 
  • Excellent for characterizing glaucoma and providing a basic glaucoma management platform
  • Threshold and screening tests for comprehensive care
  • Patient management software including Glaucoma Asymmetry Test and serial field overview for comprehensive exam results
  • Clinical validation from numerous studies documenting the Matrix's ROC curve
  • Easy and intuitive operation for users of any ability
Description The Matrix Perimeter utilizes Welch Allyn Frequency Doubling Technology. It represents a significant breakthrough in visual field testing by combining early glaucoma detection capabilities, tools to characterize glaucoma and basic glaucoma management tools.

Like the Humphrey FDT Perimeter, the Matrix doubles as an in-office glaucoma screener with 35 second supra-threshold testing. And it provides up to 69 stimuli to characterize visual field defects to facilitate accurate diagnoses.

Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. Humphrey Matrix
2. Humphrey Field Analyzer II - i series
3. Humphrey FDT Perimeter
4. Humphrey Atlas Corneal Topography Systems
5. Humphrey Refractor/Keratometer HARK 599
6. Model 350 Humphrey Lens Analyzer
7. Model 360 Humphrey Lens Analyzer
8. Humphrey Field Analyzer II - i series
9. Humphrey FDT Visual Field Instrument
10. Humphrey® Field Analyzer/HFA II-i
11. Humphrey GPA Glaucoma Progression Analysys Software
Streck-Kleen Concentrate Enzymatic Cleanser
Streck-CD3500 Hemoglobin/Lyse Lytic Reagent
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-Diluent IIIA Balanced Electrolyte Solution
Medicine Products:
(Date:11/25/2009)...re/--TheBayAreaAirQualityManagementDistrictisissui... Alert forThursday,November26,2009whichbansburn...thindoorsandoutdoors. ,, "Cold,stillweatherwill...roadbent,executiveofficeroftheAirDistrict."We,reas...borsandfellowcommunitymembersthisThanksgiving,andn...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)... out of a collaboration between UCLA engineers and...arly 10 million Americans who suffer from peripher...ng of the arteries, peripheral arterial disease, o...rrowed arteries reduce blood flow to the limbs. Th...disease, heart attack and stroke, and its progress...
(Date:11/25/2009)...hort to draw definite conclusions, experts say, ,...- In diabetic patients with blocked coronary arter... at one year whether patients undergo bypass surge...rs report. , Bypass surgery has been the standa...rtery disease. However, less invasive approaches s...
(Date:11/25/2009)... and treatment clinics to resume Monday, Nov. 30 ...er 25, 2009 -- Centegra Health System is continuin...ots at four Centegra Primary Care (CPC) vaccinatio...rived. The clinics are at CPC sites in Huntley, Wo... as follows: ,   From 4:30 to 7:30 p.m...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... Bias Correction of Familial Risk Estimates Incr...r Common Cancers , The relative risk of familial... account for a known potential bias in a large coh... have used the Swedish Cancer Registry and the Swe...
...espite recommendations from various groups, many h... TUESDAY, Sept. 9 (HealthDay News) -- According to... report giving formula sample packs to new moms, e... Adolescent Medicine , surveyed 1,295 hospitals in...
...EXFORD, Penn., Sept. 9 Millennium Pharmacy System...hnology enabled pharmacy,solutions to senior healt...of Richard Scardina as Chief Executive Officer. Mr...erving as an executive,with Caremark Rx, Inc., Ga...
... PHILADELPHIA - Researchers from the University o...a key step in the formation and suppression of e...east, head, and neck. By studying human tissue sam...t to contribute to the early stages of cancer deve...
...THENS, Ga., Sept. 9 ArunA Biomedical, Inc., the f... cell derived products and,services, announced tod...ion CFO, Harold "Bud" Ingalls, to its Board of Dir...arly 20 years of experience as a chief financial o...
...lan Challenges Policy-makers, Physicians, Patients...SHINGTON, Sept. 9 In an address today at,the Nati...E: MHS ) Chairman,and CEO, David B. Snow Jr. unve... problem. Unifying the strengths,of both the publi...
Other Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Formula Samples Hinder Breast-Feeding Efforts 2Health News:Penn researchers identify natural tumor suppressor 2Health News:ArunA Biomedical Names Harold Ingalls to its Board of Directors 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 2Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 3Health News:Medco CEO Unveils Pragmatic Blueprint for Health Care Reform; Reducing Costs by Upwards of $1 Trillion 4
(Date:11/25/2009)...ndsResearchGroup,Inc.releasedWave1ofits LaunchTre...syndicatedmarketresearchprojecttrackingthelaunchof...roughthefirstsixmonthsofavailability.Eachwaveofthe...ermatologistsandqualitativeinformationfromasubseto...touse,typicalpatienttypes,productperceptions,promo...
(Date:11/25/2009)...--RegadoBiosciences,aprivatelyheldcompanyleadingth...rolagents,announcedthatDavidMazzo,PhD,CEOandPresid...lthCareConferenceattheNewYorkPalaceHotelinNewYorkC...onTuesday,December1andwillincludeanoverviewoftheCo...gram,theanticoagulantsystem,REG1.Thehealthcareindu...
(Date:11/25/2009).../--SwissrayInternational,Inc.aleadingmanufacturero...odaythatitsoperationshavebeenacquiredbyaprivateSwi...smedicalimagingbrand.Theacquisitionincludedallasse...ntory.After25yearsofsuccessandgrowthSwissrayisnowp...tswithstableandsteadygrowth. ,, "Swissrayhaslon...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 1SpectraScience Receives FDA Approval for Enhancements to WavSTAT 28R 29 Optical Biopsy System 57419 2Scars of Bullying Linger 57417 1InVitria Cell Culture Product Line to Headline PEACe 57415 1InVitria Cell Culture Product Line to Headline PEACe 57415 2